HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $18
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has maintained its Buy rating on Kala Bio (NASDAQ:KALA) but lowered the price target from $21 to $18.

May 17, 2024 | 2:46 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. has maintained its Buy rating on Kala Bio but lowered the price target from $21 to $18.
The maintained Buy rating suggests continued confidence in Kala Bio's prospects, but the lowered price target indicates some caution. This mixed signal is likely to result in a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100